• Join
  • Login
  • Contact

Search abstracts / presentations

Prevalence of possible drug-drug interactions between ritonavir and other antiretroviral drugs in a private health care sector in South Africa

  • In: SIG: Pharmacoepidemiology/Pharmacoeconomics - Posters
  • At: Basel (Switzerland) (2008)
  • Type: Poster
  • Poster code: PP-P-003
  • By: TRUTER, Ilse (Drug Utilization Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa)
  • Co-author(s): Katende-Kyenda, Norah (Department of Pharmacology, Walter Sisulu University, Mthatha, South Africa)
    Lubbe, Martie (Pharmacy Practice, North-West University, Potchefstroom, South Africa)
    Serfontein, Jan (Pharmacy Practice, North-West University, Potchefstroom, South Africa)
  • Abstract:

    Background: The introduction of human immunodeficiency virus (HIV) protease inhibitors (PIs) has led to a dramatic decline in the morbidity and mortality associated with HIV infection, though concomitant use of PIs and other antiretrovirals (ARVs) can be complicated by drug-drug interactions (DDIs), adversely affecting levels of PIs.
    Primary aim:


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses